D-1174-2017 Class II Terminated
FDA drug recall D-1174-2017 was initiated by Medisca, Inc. on Sep 14, 2017 and is designated Class II. Reason for recall: CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use. The recall status is terminated (terminated Dec 4, 2018). Affected quantity: 34,600 g.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 27, 2017
- Initiation Date
- Sep 14, 2017
- Termination Date
- Dec 4, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 34,600 g
Product description
Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989-05, b) 1 kg jar (NDC 38779-0989-09), and 25 kg drum (NDC 38779-0989-07), Rx only, Packed by Medisca Inc., Plattsburgh, NY 12901, CAS: 60-32-1. 38779-0989-05; jar, 300 ml, white HDPE 38779-0989-07; drum, 15 gallon, Fiber 38779-0989-09; 2.8L, white, HDPE
Reason for recall
CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.
Distribution pattern
Nationwide in the USA
Code information
Lots# 143595/A,143595/B,143595/D, Exp 02/28/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1174-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026